TY - JOUR
T1 - Physical illnesses before diagnosed as schizophrenia
T2 - A nationwide case-control study
AU - Chen, Yi Lung
AU - Pan, Chun Hung
AU - Chang, Chi Kang
AU - Chen, Pao Huan
AU - Chang, Hu Ming
AU - Tai, Ming Hong
AU - Su, Sheng Shiang
AU - Tsai, Shang Ying
AU - Chen, Chiao Chicy
AU - Kuo, Chian Jue
N1 - Funding Information:
This research was supported by grants from the Ministry of Science and Technology, Taiwan (MOST 105-2314-B-532-006-MY3 and MOST 108-2314-B-532- 005) and Taipei City Hospital (10701-62-023 and 10801- 62-004). The funding sources were not involved in the study design, data collection, data analysis, data interpretation, report writing, or the decision to submit the article for publication.
Publisher Copyright:
© The Author(s) 2020.
PY - 2020/7/1
Y1 - 2020/7/1
N2 - Some physical illnesses are potentially associated with the development of schizophrenia. However, few studies have investigated these associations. Here, we examined physical illnesses and medical utilization patterns existing before patients received a diagnosis of schizophrenia. We enrolled a large representative cohort of the general population in Taiwan (N = 1 000 000) and identified 1969 young patients with a new diagnosis of schizophrenia from January 1, 2000 to December 31, 2013. We conducted a nested casecontrol study based on risk-set sampling. Each case was age-matched and sex-matched with 4 controls selected from the general population. The case and control groups were compared on the basis of various clinical characteristics. Conditional logistic regression was used to estimate the magnitude of risk associated with newly diagnosed schizophrenia. Within the 1 year before the schizophrenia diagnosis, the cases were most likely to visit the psychiatry department, followed by internal medicine and family medicine departments. According to multivariate analysis, compared with the controls, the cases had substantially higher risk of physical conditions in the prodromal phase, including hypertension (adjusted risk ratio [aRR] = 1.93, P = .001), other forms of heart disease (aRR = 2.07, P < .001), cerebrovascular diseases (aRR = 2.96, P = .001), chronic obstructive pulmonary disease (aRR = 1.50, P = .005), asthma (aRR = 1.76, P = .003), and irritable bowel syndrome (aRR = 2.00, P < .001). A wide range of psychiatric diseases and concomitant use of medications were significantly associated with schizophrenia development. In conclusion, several physical illnesses were identified to be associated with schizophrenia development, indicating that people with these illnesses could be vulnerable to schizophrenia.
AB - Some physical illnesses are potentially associated with the development of schizophrenia. However, few studies have investigated these associations. Here, we examined physical illnesses and medical utilization patterns existing before patients received a diagnosis of schizophrenia. We enrolled a large representative cohort of the general population in Taiwan (N = 1 000 000) and identified 1969 young patients with a new diagnosis of schizophrenia from January 1, 2000 to December 31, 2013. We conducted a nested casecontrol study based on risk-set sampling. Each case was age-matched and sex-matched with 4 controls selected from the general population. The case and control groups were compared on the basis of various clinical characteristics. Conditional logistic regression was used to estimate the magnitude of risk associated with newly diagnosed schizophrenia. Within the 1 year before the schizophrenia diagnosis, the cases were most likely to visit the psychiatry department, followed by internal medicine and family medicine departments. According to multivariate analysis, compared with the controls, the cases had substantially higher risk of physical conditions in the prodromal phase, including hypertension (adjusted risk ratio [aRR] = 1.93, P = .001), other forms of heart disease (aRR = 2.07, P < .001), cerebrovascular diseases (aRR = 2.96, P = .001), chronic obstructive pulmonary disease (aRR = 1.50, P = .005), asthma (aRR = 1.76, P = .003), and irritable bowel syndrome (aRR = 2.00, P < .001). A wide range of psychiatric diseases and concomitant use of medications were significantly associated with schizophrenia development. In conclusion, several physical illnesses were identified to be associated with schizophrenia development, indicating that people with these illnesses could be vulnerable to schizophrenia.
KW - Medical utilization
KW - Nested case-control study
KW - Physical comorbidities
KW - Psychiatric comorbidity
KW - Schizophrenia
UR - http://www.scopus.com/inward/record.url?scp=85088210663&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85088210663&partnerID=8YFLogxK
U2 - 10.1093/schbul/sbaa009
DO - 10.1093/schbul/sbaa009
M3 - Article
C2 - 32052838
AN - SCOPUS:85088210663
SN - 0586-7614
VL - 46
SP - 785
EP - 794
JO - Schizophrenia bulletin
JF - Schizophrenia bulletin
IS - 4
ER -